Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.
2.

Immunophenotype of a transient myeloproliferative disorder in a newborn with trisomy 21.

Girodon F, Favre B, Couillaud G, Carli PM, Parmeland C, Maynadié M.

Cytometry. 2000 Apr 15;42(2):118-22.

PMID:
10797450
3.

Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.

Hayashi Y, Eguchi M, Sugita K, Nakazawa S, Sato T, Kojima S, Bessho F, Konishi S, Inaba T, Hanada R, et al.

Blood. 1988 Jul;72(1):15-23.

4.

Transient myeloproliferative disorder causing a vesiculopustular eruption in a phenotypically normal neonate.

Solky BA, Yang FC, Xu X, Levins P.

Pediatr Dermatol. 2004 Sep-Oct;21(5):551-4.

PMID:
15461760
5.

Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: report of two cases with trisomy 21 mosaicism.

Zubizarreta P, Muriel FS, Fernández Barbieri MA.

Med Pediatr Oncol. 1995 Jul;25(1):60-4.

PMID:
7753004
6.

[Transient myeloproliferative disorder in a neonate without Down syndrome].

Adam M, Vincenot A, Gouraud F, Harvel C, Perot C, Portnoi MF, Andre-Kerneis E, Giraudier S, Leverger G, Favier R.

Ann Biol Clin (Paris). 2007 Sep-Oct;65(5):569-73. French.

7.

Transient myeloproliferative disorder in chromosomally normal newborn infant.

Kalousek DK, Chan KW.

Med Pediatr Oncol. 1987;15(1):38-41.

PMID:
2951583
8.

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.

Heald B, Hilden JM, Zbuk K, Norton A, Vyas P, Theil KS, Eng C.

Nat Clin Pract Oncol. 2007 Jul;4(7):433-8.

PMID:
17597708
11.

Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.

Smrcek JM, Baschat AA, Germer U, Gloeckner-Hofmann K, Gembruch U.

Ultrasound Obstet Gynecol. 2001 May;17(5):403-9.

12.

Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.

Prabhu PD, V G, Niveditha SR, Gayathri BR, Keshavamurthy SR.

Indian J Pathol Microbiol. 2004 Jan;47(1):48-50. Review.

PMID:
15471129
13.

Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.

Zipursky A, Brown EJ, Christensen H, Doyle J.

Clin Lab Med. 1999 Mar;19(1):157-67, vii. Review.

PMID:
10403079
14.
15.

[Transient neonatal myeloproliferative disorder in the absence of Down syndrome].

Bastida Vilá P, Olivé Oliveras T, Díaz de Heredia Rubio C, Ortega Aramburu JJ.

An Pediatr (Barc). 2004 Dec;61(6):546-50. Spanish.

16.

Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with Down syndrome.

Barnett PL, Clark AC, Garson OM.

Med Pediatr Oncol. 1990;18(5):347-53. Review.

PMID:
2142749
17.

WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.

Hasle H, Lund B, Nyvold CG, Hokland P, Østergaard M.

Leuk Res. 2006 May;30(5):543-6.

PMID:
16242775
18.

Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.

Cushing T, Clericuzio CL, Wilson CS, Taub JW, Ge Y, Reichard KK, Winter SS.

J Pediatr. 2006 May;148(5):687-9.

PMID:
16737888
19.

Late diagnosis of Down syndrome due to incorrect cytogenetic diagnosis and extreme prematurity.

Druce M, Cohen IJ, Naor N, Shohat M.

Clin Genet. 1995 Oct;48(4):192-4.

PMID:
8591670
20.

Supplemental Content

Support Center